August 24, 2020 - Biologics by McKesson was selected by Taiho Oncology, Inc. as a specialty pharmacy provider for INQOVI (decitabine and cedazuridine) tablets for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies. INQOVI, approved by the U.S. Food and Drug … [Read more...]
XPOVIO (selinexor), FDA approved for treatment of relapsed or refractory diffuse large B-cell Lymphoma (DLBCL), available at Biologics by McKesson
Biologics by McKesson, an independent specialty pharmacy specializing in oncology, rare diseases and other complex therapeutic areas, was selected by Karyopharm Therapeutics, Inc. as a specialty pharmacy provider for XPOVIO (selinexor) for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (RR DLBCL), not otherwise specified, including … [Read more...]